Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Gw Pharmaceuticals (GWP)

GW Pharm.
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GWP
DateTimeSourceHeadlineSymbolCompany
30/05/201317:30UK RegulatoryGW Pharmaceuticals PLC Exercise of Over-Allotment OptionLSE:GWPGW Pharm.
14/05/201313:00UK RegulatoryGW Pharmaceuticals PLC Notice of ResultsLSE:GWPGW Pharm.
14/05/201313:00PR Newswire (US)GW Pharmaceuticals to Report Interim 2013 Results and Host Conference Call on 3 June, 2013LSE:GWPGW Pharm.
10/05/201316:28UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
10/05/201316:24UK RegulatoryGW Pharmaceuticals PLC Holding(s) in CompanyLSE:GWPGW Pharm.
09/05/201315:40UK RegulatoryGW Pharmaceuticals PLC Total Voting RightsLSE:GWPGW Pharm.
08/05/201308:00UK RegulatoryGW Pharmaceuticals PLC Closing of Initial Public Offering on NasdaqLSE:GWPGW Pharm.
08/05/201308:00PR Newswire (US)GW Pharmaceuticals plc Announces the Closing of its Initial Public Offering on the Nasdaq Global MarketLSE:GWPGW Pharm.
07/05/201307:00UK RegulatoryGW Pharmaceuticals PLC Sativex Commercialization Approval in ItalyLSE:GWPGW Pharm.
07/05/201307:00PR Newswire (US)GW Pharmaceuticals plc Announces Sativex® Commercialization Approval in ItalyLSE:GWPGW Pharm.
01/05/201317:47UK RegulatoryGW Pharmaceuticals PLC Pricing of U.S. Initial Public OfferingLSE:GWPGW Pharm.
01/05/201317:43PR Newswire (US)GW Pharmaceuticals Announces Pricing of Initial Public Offering on the NASDAQ Global MarketLSE:GWPGW Pharm.
22/04/201307:00UK RegulatoryGW Pharmaceuticals PLC US Patent Allowance for SATIVEX Formulation SprayLSE:GWPGW Pharm.
18/04/201314:23UK RegulatoryGW Pharmaceuticals PLC Amendment to Registration Statement for NASDAQLSE:GWPGW Pharm.
12/04/201310:31UK RegulatoryGW Pharmaceuticals PLC Results of General MeetingLSE:GWPGW Pharm.
10/04/201307:00UK RegulatoryGW Pharmaceuticals PLC Sativex moved to Schedule 4 of UK Drugs ActLSE:GWPGW Pharm.
03/04/201307:00UK RegulatoryGW Pharmaceuticals PLC New US Patent Allowance for Delivery of SATIVEXLSE:GWPGW Pharm.
22/03/201314:35UK RegulatoryGW Pharmaceuticals PLC Posting of Shareholder CircularLSE:GWPGW Pharm.
19/03/201314:46RNS Non-RegulatoryGW Pharmaceuticals PLC Appoints Stephen Schultz VP of Investor RelationsLSE:GWPGW Pharm.
19/03/201313:46PR Newswire (US)GW Pharmaceuticals Files Registration Statement for NASDAQ Global Market Listing and U.S. Initial Public OfferingLSE:GWPGW Pharm.
19/03/201313:10UK RegulatoryGW Pharmaceuticals PLC Update on Sativex in GermanyLSE:GWPGW Pharm.
19/03/201313:01UK RegulatoryGW Pharmaceuticals PLC Filing for listing on NASDAQLSE:GWPGW Pharm.
19/02/201315:16UK RegulatoryGW Pharmaceuticals PLC Directorate ChangeLSE:GWPGW Pharm.
19/02/201309:30UK RegulatoryGW Pharmaceuticals PLC Blocklisting Interim ReviewLSE:GWPGW Pharm.
21/01/201311:44UK RegulatoryGW Pharmaceuticals PLC Result of AGMLSE:GWPGW Pharm.
04/12/201210:04UK RegulatoryGW Pharmaceuticals PLC Director/PDMR ShareholdingLSE:GWPGW Pharm.
30/11/201214:54UK RegulatoryGW Pharmaceuticals PLC Director/PDMR ShareholdingLSE:GWPGW Pharm.
30/11/201214:50UK RegulatoryGW Pharmaceuticals PLC Director/PDMR ShareholdingLSE:GWPGW Pharm.
28/11/201207:00UK RegulatoryGW Pharmaceuticals PLC Preliminary ResultsLSE:GWPGW Pharm.
28/11/201207:00UK RegulatoryGW Pharmaceuticals PLC PhIIa Study Identifies New Anti-Diabetic TreatmentLSE:GWPGW Pharm.
 Showing the most relevant articles for your search:LSE:GWP